Entities / Company
Thermo Fisher Scientific Inc..
multinational company providing scientific instrumentation
- Reports this week
- 1
- Active events
- 1
- Connections
- 228
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
-
Eldred Rock Partners LLC increased its stake in Thermo Fisher Scientific Inc. on August 8, 2026, requiring filings with the SEC.Some support3 reports
-
Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.Some support1 report
-
Analyst firms RBC, CLSA, Morgan Stanley, and Jefferies Financial Group provided rating and price target updates for Thermo Fisher Scientific on September 8, 2026.Some support1 report1 development inside
-
HSBC raised its rating to strong-buy and Morgan Stanley raised its target price for Thermo Fisher Scientific Inc.Some support2 reports
-
Qiagen and Thermo Fisher Scientific Inc. were compared based on financial metrics on September 15, 2026.Some support2 reports
-
Strategic corporate announcements made on June 25, 2025, detail acquisition plans, integrations, and portfolio expansions for several medical technology companies.Speculative1 report1 development inside
-
PPD plans to open a clinical research facility in Greenfield, with local officials discussing incentives for the new site.Some support1 report
-
Thermo Fisher Scientific Inc. and iSpecimen are two healthcare companies that are currently competing for market share.Some support1 report
-
Glyn Davies is president of materials analysis, and David Muller is a professor at Cornell University.Some support2 reports
-
Royal Bank of Canada raised its target price on Thermo Fisher Scientific Inc. on August 29, 2026, coinciding with Lombard Odier buying a new position in the company's shares.Some support1 report
-
HSBC purchased a new position in Thermo Fisher Scientific stock and lowered its shares rating and target price.Some support1 report
-
Thermo Fisher Scientific Inc., based in Waltham, MA, is facing stock performance issues compared to the S&P 500, with analyst coverage available.Some support1 report
-
Thermo Fisher Scientific Inc. filed required reports with the SEC on June 16, 2026, influenced by analyst reports from Morgan Stanley.Some support6 reports
-
Liberty Capital bought a new stake in TMO stock.Some support1 report
Gone quiet
No new reports in 90+ days-
Market growth in the Microtome Market is being driven by advanced diagnostics, with companies like Leica Biosystems, Thermo Fisher Scientific Inc., and Sakura Finetek involved, providing data on cancer incidence.Some support1 report1 development inside
-
Chief Accounting Officer of Thermo Fisher Scientific Inc. sold company shares.Some support2 reports
-
Danaher Corporation and Thermo Fisher Scientific Inc. are competing in the life sciences tools market.Some support2 reports
-
MarketBeat reports on consensus price targets and analyst recommendations for Thermo Fisher Scientific and Solana.Some support2 reports
-
Leerink Partners raised price target for Thermo Fisher Scientific Inc. (TMO) on July 23, 2026.Some support2 reports
-
Thermo Fisher Scientific and Twist Bioscience benefit from Trump-era tariffs while operating in the life sciences sector.Some support1 report
-
Thermo Fisher Scientific Inc. (TMO) is advancing Treg cell therapies, benefiting from Trump-era tariffs, and features Andy Campbell as a senior director.Speculative2 reports
-
Bio-Techne and Thermo Fisher Scientific Inc. are being monitored for peer company performance comparison in the market.Some support1 report
-
Quest Diagnostics and Thermo Fisher Scientific Inc. are noted as providers in the diagnostic/scientific field, with stock performance compared to the SPX index.Some support2 reports
-
The State of Wisconsin Investment Board decreased its stock holdings, while Norges Bank acquired a new stock position.Some support1 report
-
Taikang Asset Management Hong Kong Co Ltd reduced its position in the shares of Thermo Fisher Scientific Inc.Some support1 report
-
Piper Sandler initiated coverage of TMO, noting that the company operates across North America, Europe, and Asia-Pacific.Some support1 report
-
Thermo Fisher Scientific's COO sold company stock under a 10b5-1 plan, requiring disclosure of institutional holdings changes.Some support1 report
-
Thermo Fisher Scientific Inc. stock underperformed its rival TMO while serving customers across the Americas.Some support2 reports
-
U.S.–China trade tensions are impacting China sales for Thermo Fisher Scientific Inc.Speculative1 report
-
Thermo Fisher Scientific Inc. benefits from Trump-era tariffs and onshoring, leading to Wells Fargo reaffirming a 'Buy' rating.Some support3 reports
-
Quest Diagnostics outperformed its rival Thermo Fisher Scientific Inc. in a recent market comparison.Speculative1 report
-
Thermo Fisher Scientific Inc. was awarded a $94.5 million contract by the US Department of Defense on June 26, 2025, to supply a next-gen dosimetry system.Speculative2 reports
-
Exponent and Thermo Fisher Scientific Inc. were noted for offering high-value services in complex technical fields.Speculative1 report
-
Ethris and Thermo Fisher Scientific Inc. announced a partnership on June 25, 2025, aimed at providing integrated mRNA solutions.Speculative1 report
-
Thermo Fisher Scientific received a Buy rating from Wells Fargo and an amendment to its agreement with SOLVE was announced.Speculative1 report
-
SDi provided market intelligence identifying Agilent, Carl Zeiss AG, and Thermo Fisher Scientific Inc. as top instrument vendors.Speculative1 report
-
Jim Cramer included Thermo Fisher Scientific Inc. in his stock radar on July 2, 2025.Speculative1 report
-
Solventum sold its Purification & Filtration business to Thermo Fisher Scientific in September 2025.Well supported3 reports1 development inside
-
An amendment to the acquisition deal excludes the water filtration business from Solventum's sale to Thermo Fisher Scientific.Speculative1 report
-
FDA approved Oncomine Dx Express Test, a companion diagnostic for Dizal's drug.Speculative2 reports
-
Sap and Thermo Fisher Scientific Inc. were featured together in research reports on July 10, 2025.Some support1 report
-
Bio-Rad (Israel), Thermo Fisher Scientific Inc., and Qiagen (UK) are strategically engaging in mergers and R&D to enhance market presence.Some support1 report
-
Goldman Sachs named Thermo Fisher Scientific Inc. (TMO) a top healthcare stock pick on July 15, 2025.Some support1 report
-
Bruker, Mettler-Toledo, and Thermo Fisher Scientific operate in the research tools and consumables segment.Some support3 reports1 development inside
-
Thermo Fisher Scientific Inc. and Merck are major players in the residual DNA testing market as of August 5, 2025.Some support2 reports
-
Kovitz Investment Group Partners, LLC increased its position in Thermo Fisher Scientific Inc. stock on August 6, 2025.Some support1 report
-
Positive inflation data fueled stock gains for IQVIA and Thermo Fisher Scientific Inc. on August 13, 2025.Some support1 report
-
Agilent Technologies, Thermo Fisher Scientific Inc., and Merck KGaA are leading in the peptide synthesis market.Some support2 reports
-
An acquisition occurred on August 14, 2025, involving Life Technologies, leading to the formation of the Life Sciences Solutions and Specialty Diagnostics segments.Some support1 report
-
TMO stock performance was compared to the Dow Jones Industrial Average starting around September 2025.Some support2 reports1 development inside
-
TMO stock underperformed the S&P 500 Index and the Health Care Select Sector SPDR Fund on August 18, 2025.Some support1 report
-
As of August 18, 2025, Thermo Fisher Scientific Inc. was identified as a top holding within the Parnassus fund.Some support1 report
-
Beckman Coulter and Thermo Fisher Scientific operate in the lab equipment market, utilizing European Medicines Agency fast-track schemes.Some support2 reports
-
Thermo Fisher Scientific opened a new manufacturing center of excellence site in Mebane, North Carolina, strengthening its capabilities and supply chain.Some support1 report
-
Illumina and Thermo Fisher Scientific are key players in the DNA forensics market.Some support1 report
-
Thermo Fisher offers brands including Invitrogen and Applied Biosystems.Some support3 reports
-
Leading players IQVIA, Thermo Fisher, and ICON compete in the Central Lab Services market, according to a report published in Dublin.Some support1 report
-
Danaher, Thermo Fisher Scientific, and Agilent Technologies are focused on dominating the global PFAS Testing market.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Thermo Fisher Scientific Inc.
Events traced to Thermo Fisher Scientific Inc., step by step, newest firstAround Thermo Fisher Scientific Inc. this week
News at the entities that move Thermo Fisher Scientific Inc. most-
Securities and Exchange Commission StructuralConnect Biopharma Holdings Limited filed disclosures with the SEC and its stock is traded on the Nasdaq exchange.Moves Thermo Fisher Scientific Inc.
-
SEC StructuralMSCI index rules may affect Bitcoin companies, while warnings caused stock market crashes in Turkey and Indonesia.Moves Thermo Fisher Scientific Inc.
-
Morgan Stanley OperationalAmazon is attempting to challenge Google's search dominance while Morgan Stanley reports highlight shopper behavior trends.Moves Thermo Fisher Scientific Inc.
-
Donald Trump Shared contextDemocratic leaders Schumer and Jeffries are facing internal political limitations and hindering legislative progress.Moves Thermo Fisher Scientific Inc.
-
Danaher Corporation OperationalDanaher Corporation disclosed filings with the SEC, and Fifth Third Bancorp reduced its position in Danaher.Moves Thermo Fisher Scientific Inc.
-
Royal Bank of Canada Mentioned togetherMorgan Stanley began coverage of Vylor with an 'overweight' rating, while Royal Bank of Canada authorized a $3.00 billion stock buyback plan.Moves Thermo Fisher Scientific Inc.
Connections
The 40 strongest of 228, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Pharmaceutical Product Development Structural
Thermo Fisher Scientific acquired Pharmaceutical Product Development in 2021 for $17.4 billion.
-
TMO Structural
TMO functions as the official stock ticker and brand identifier for Thermo Fisher Scientific Inc.
-
Invitrogen Structural
Thermo Fisher Scientific owns Invitrogen, which is maintained as an industry-leading brand and subsidiary.
-
Applied Biosystems Structural
Thermo Fisher Scientific Inc. owns Applied Biosystems, which is maintained as a subsidiary and industry brand.
-
Danaher Corporation Operational
The two companies are direct competitors in specialized life sciences markets, including oligonucleotide synthesis, PFAS testing, and life sciences tools.
-
Quest Diagnostics Operational
The two companies are direct, active competitors in the diagnostic and life science markets.
-
Securities and Exchange Commission Structural
Thermo Fisher Scientific Inc. is subject to formal regulatory requirements by the SEC regarding financial disclosures.
-
Sanofi Structural
Thermo Fisher acquired Sanofi's manufacturing site and continues to produce therapies for Sanofi.
Show all 40 connections
-
SEC Structural
Thermo Fisher Scientific Inc. is subject to formal filing and oversight requirements imposed by the SEC.
-
Glyn Davies Structural
Glyn Davies serves as the president of materials analysis for Thermo Fisher Scientific Inc.
-
Eli Lilly and Company Structural
Thermo Fisher supplies essential reagents required for Eli Lilly's drug production process.
-
Agilent Technologies Operational
Agilent and Thermo Fisher are direct competitors dominating specialized markets like mass spectrometry and peptide synthesis.
-
Joseph Holmes Structural
Joseph Holmes serves as the Chief Accounting Officer of Thermo Fisher Scientific Inc.
-
Morgan Stanley Operational
Morgan Stanley influences market perception of Thermo Fisher Scientific Inc. through analyst reports and target price recommendations.
-
Mohan Iyer Structural
Mohan Iyer is employed as a vice president at Thermo Fisher Scientific Inc.
-
Bio-Techne Operational
The two companies are actively engaged in competition within the market through peer performance comparisons.
-
Donald Trump Shared context
Thermo Fisher benefits from economic policies and tariffs associated with Donald Trump's political era.
-
Waters Corporation Operational
Waters Corporation and Thermo Fisher Scientific Inc. are active competitors operating within the research tools and consumables market segment.
-
HSBC Mentioned together
HSBC provided analyst ratings on Thermo Fisher Scientific Inc., changing from a lowered rating to a strong-buy recommendation.
-
State of Wisconsin Investment Board Transactional
The State of Wisconsin Investment Board reduced its stock holdings in Thermo Fisher Scientific Inc.
-
Abbott Laboratories Operational
The companies are major healthcare providers and compete in the market.
-
BioNano Genomics Mentioned together
Both companies are noted as healthcare entities competing for investment capital.
-
Rapid Micro Biosystems Operational
Rapid Micro Biosystems and Thermo Fisher Scientific compete in the life sciences and healthcare market.
-
Qiagen Mentioned together
The companies are frequently co-mentioned in financial reports and comparisons.
-
Johnson & Johnson Shared context
Both companies operate within the large-scale healthcare and life sciences markets, sharing a common industry context.
-
Leerink partners Mentioned together
Leerink Partners issued rating upgrades and price targets for Thermo Fisher Scientific, influencing market perception.
-
Solana Operational
The evidence suggests both entities are viewed as competitors within the medical industry.
-
Americas Shared context
Thermo Fisher operates as a business entity whose customer base spans the geographical region of the Americas.
-
MarketBeat Mentioned together
MarketBeat lists Thermo Fisher Scientific as a stock to watch in its coverage.
-
SPX Mentioned together
Thermo Fisher Scientific's stock performance was observed to lag behind the S&P 500 Index.
-
STEM Mentioned together
Both companies are mentioned in the context of developing advanced detector technology for materials science.
-
Casper Operational
The evidence suggests they operate in the same market space, though the specific nature of the interaction is undefined.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides buy ratings and price targets for Thermo Fisher Scientific Inc.
-
Goldman Sachs Mentioned together
Goldman Sachs provides investment analysis and commentary regarding Thermo Fisher Scientific Inc.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada raised its price target on Thermo Fisher Scientific Inc.
-
Wells Fargo Mentioned together
Wells Fargo provides financial ratings and analyst coverage on Thermo Fisher Scientific Inc.
-
Twist Bioscience Shared context
The two companies share the life sciences sector as their operational context.
-
CLSA Mentioned together
CLSA provided an outperform rating and started coverage on Thermo Fisher Scientific Inc.
-
Waltham Shared context
The company is headquartered and operates from its base in Waltham, Massachusetts.
-
Buy Mentioned together
The provided evidence does not contain a direct observation linking Buy and Thermo Fisher Scientific Inc.
History
Events by the month they beganNovember 2026
2 eventsSeptember 2026
5 events- Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.
- Analyst firms RBC, CLSA, Morgan Stanley, and Jefferies Financial Group provided rating and price target updates for Thermo Fisher Scientific on September 8, 2026.
- HSBC raised its rating to strong-buy and Morgan Stanley raised its target price for Thermo Fisher Scientific Inc.
- Qiagen and Thermo Fisher Scientific Inc. were compared based on financial metrics on September 15, 2026.
- PPD plans to open a clinical research facility in Greenfield, with local officials discussing incentives for the new site.
August 2026
9 events- Eldred Rock Partners LLC increased its stake in Thermo Fisher Scientific Inc. on August 8, 2026, requiring filings with the SEC.
- Thermo Fisher Scientific Inc. and iSpecimen are two healthcare companies that are currently competing for market share.
- Glyn Davies is president of materials analysis, and David Muller is a professor at Cornell University.
- Royal Bank of Canada raised its target price on Thermo Fisher Scientific Inc. on August 29, 2026, coinciding with Lombard Odier buying a new position in the company's shares.
- HSBC purchased a new position in Thermo Fisher Scientific stock and lowered its shares rating and target price.
- Thermo Fisher Scientific Inc., based in Waltham, MA, is facing stock performance issues compared to the S&P 500, with analyst coverage available.
- Liberty Capital bought a new stake in TMO stock.
- Chief Accounting Officer of Thermo Fisher Scientific Inc. sold company shares.
- Danaher Corporation and Thermo Fisher Scientific Inc. are competing in the life sciences tools market.
Show 2 earlier months
July 2026
2 eventsJune 2026
42 events- Strategic corporate announcements made on June 25, 2025, detail acquisition plans, integrations, and portfolio expansions for several medical technology companies.
- Thermo Fisher Scientific Inc. filed required reports with the SEC on June 16, 2026, influenced by analyst reports from Morgan Stanley.
- Market growth in the Microtome Market is being driven by advanced diagnostics, with companies like Leica Biosystems, Thermo Fisher Scientific Inc., and Sakura Finetek involved, providing data on cancer incidence.
- Thermo Fisher Scientific and Twist Bioscience benefit from Trump-era tariffs while operating in the life sciences sector.
- Thermo Fisher Scientific Inc. (TMO) is advancing Treg cell therapies, benefiting from Trump-era tariffs, and features Andy Campbell as a senior director.
- Bio-Techne and Thermo Fisher Scientific Inc. are being monitored for peer company performance comparison in the market.
- Quest Diagnostics and Thermo Fisher Scientific Inc. are noted as providers in the diagnostic/scientific field, with stock performance compared to the SPX index.
- The State of Wisconsin Investment Board decreased its stock holdings, while Norges Bank acquired a new stock position.
- Taikang Asset Management Hong Kong Co Ltd reduced its position in the shares of Thermo Fisher Scientific Inc.
- Piper Sandler initiated coverage of TMO, noting that the company operates across North America, Europe, and Asia-Pacific.
- Thermo Fisher Scientific's COO sold company stock under a 10b5-1 plan, requiring disclosure of institutional holdings changes.
- Thermo Fisher Scientific Inc. stock underperformed its rival TMO while serving customers across the Americas.
- U.S.–China trade tensions are impacting China sales for Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. benefits from Trump-era tariffs and onshoring, leading to Wells Fargo reaffirming a 'Buy' rating.
- Quest Diagnostics outperformed its rival Thermo Fisher Scientific Inc. in a recent market comparison.
- Thermo Fisher Scientific Inc. was awarded a $94.5 million contract by the US Department of Defense on June 26, 2025, to supply a next-gen dosimetry system.
- Exponent and Thermo Fisher Scientific Inc. were noted for offering high-value services in complex technical fields.
- Ethris and Thermo Fisher Scientific Inc. announced a partnership on June 25, 2025, aimed at providing integrated mRNA solutions.
- Thermo Fisher Scientific received a Buy rating from Wells Fargo and an amendment to its agreement with SOLVE was announced.
- SDi provided market intelligence identifying Agilent, Carl Zeiss AG, and Thermo Fisher Scientific Inc. as top instrument vendors.
- Jim Cramer included Thermo Fisher Scientific Inc. in his stock radar on July 2, 2025.
- Solventum sold its Purification & Filtration business to Thermo Fisher Scientific in September 2025.
- An amendment to the acquisition deal excludes the water filtration business from Solventum's sale to Thermo Fisher Scientific.
- FDA approved Oncomine Dx Express Test, a companion diagnostic for Dizal's drug.
- Sap and Thermo Fisher Scientific Inc. were featured together in research reports on July 10, 2025.
- Bio-Rad (Israel), Thermo Fisher Scientific Inc., and Qiagen (UK) are strategically engaging in mergers and R&D to enhance market presence.
- Goldman Sachs named Thermo Fisher Scientific Inc. (TMO) a top healthcare stock pick on July 15, 2025.
- Bruker, Mettler-Toledo, and Thermo Fisher Scientific operate in the research tools and consumables segment.
- Thermo Fisher Scientific Inc. and Merck are major players in the residual DNA testing market as of August 5, 2025.
- Kovitz Investment Group Partners, LLC increased its position in Thermo Fisher Scientific Inc. stock on August 6, 2025.
- Positive inflation data fueled stock gains for IQVIA and Thermo Fisher Scientific Inc. on August 13, 2025.
- Agilent Technologies, Thermo Fisher Scientific Inc., and Merck KGaA are leading in the peptide synthesis market.
- An acquisition occurred on August 14, 2025, involving Life Technologies, leading to the formation of the Life Sciences Solutions and Specialty Diagnostics segments.
- TMO stock performance was compared to the Dow Jones Industrial Average starting around September 2025.
- TMO stock underperformed the S&P 500 Index and the Health Care Select Sector SPDR Fund on August 18, 2025.
- As of August 18, 2025, Thermo Fisher Scientific Inc. was identified as a top holding within the Parnassus fund.
- Beckman Coulter and Thermo Fisher Scientific operate in the lab equipment market, utilizing European Medicines Agency fast-track schemes.
- Thermo Fisher Scientific opened a new manufacturing center of excellence site in Mebane, North Carolina, strengthening its capabilities and supply chain.
- Illumina and Thermo Fisher Scientific are key players in the DNA forensics market.
- Thermo Fisher offers brands including Invitrogen and Applied Biosystems.
- Leading players IQVIA, Thermo Fisher, and ICON compete in the Central Lab Services market, according to a report published in Dublin.
- Danaher, Thermo Fisher Scientific, and Agilent Technologies are focused on dominating the global PFAS Testing market.